Aposave fully established in new UK commercial hub

With powerful backing, Simon Estcourt and team are ready to challenge the industry status quo

11/FEBRUARY/2020

“Aposave is an incredibly exciting company. Historically no healthcare and pharma services organisation has had the backing of such a powerful parent organisation.
With our portfolio of services from Clinical Trial Solutions to Managed Access Programmes, Specialty Commercial Distribution and our new unlicensed medicines service, we are hugely excited about the new decade,” says Simon Estcourt, Aposave Managing Director.”

Aposave is part of Abacus Medicine, the fastest growing distributor of original prescription medicines in Europe. With a customised ERP system, a bespoke global distribution centre and a leadership team with decades of experience, Aposave is aiming to become the next-generation healthcare and pharma services company.

“Combining the infrastructure and skills at Abacus Medicine with the experience and expertise here within Aposave, we truly have the capability of becoming the next generation of healthcare and pharma services organisation.”

A history of growth
Abacus Medicine was founded by Flemming Wagner and his father Dr John Wagner in 2004 to improve the access of specialty medicines in Europe. By 2019 it was the fastest growing company in this market with over 800 employees across 7 global locations and expected revenues in the range of EUR 400 – 445M. They lead the field in open market sourcing with cutting edge IT capabilities and over 3,000 marketing authorisations.

The success of Abacus Medicine in Europe led to orders from across the globe. The scene was set for a new member of the Abacus Medicine Group of Companies. In 2013 Aposave UK was incorporated, followed quickly by operations in North America, Asia and Copenhagen.

2018 saw the recruitment of Simon Estcourt as Aposave’s first Managing Director. With a wealth of experience in this field, Simon and his teams have revolutionised the access of new medicines and addressed the challenges of unmet medical need across the globe over the past 15 years. Through 2019 a series of highly experienced executives were hand-picked and joined Aposave UK in the new international commercial hub based in Farnborough, Hampshire.